NASDAQ: CTXRCitius Pharmaceuticals Inc Stock Ownership - Who owns Citius Pharmaceuticals?
Insider buying vs selling
Have Citius Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CTXR insiders and whales buy or sell their stock.
CTXR Shareholders
What type of owners hold Citius Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Leonard L. Mazur | 2.41% | 410,214 | $619.42k | Insider |
| Ubs Group Ag | 1.13% | 192,927 | $291.32k | Institution |
| Cambridge Investment Research Advisors Inc | 1.08% | 183,534 | $277.14k | Institution |
| Heights Capital Management Inc | 0.94% | 159,898 | $241.45k | Institution |
| Vanguard Group Inc | 0.47% | 80,103 | $120.96k | Institution |
| Myron Z. Holubiak | 0.47% | 79,690 | $120.33k | Insider |
| Geode Capital Management LLC | 0.45% | 76,095 | $114.90k | Institution |
| Blackrock Inc | 0.41% | 69,851 | $105.48k | Institution |
| Jaime Bartushak | 0.35% | 60,353 | $91.13k | Insider |
| Newedge Advisors LLC | 0.15% | 25,000 | $37.75k | Institution |
CTXR vs Biotech Stocks
Citius Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.